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ABSTRACT 
 Ubiquitin (UB) cascades in vivo are complex to study with cross-reactivity of E1-E2 
pairs, E2-E3 pairs, and E3-substrate pairs. RNF38, RING finger protein 38, is a RING-type E3 
ligase in the UB transfer cascade in the cell, and the role of RNF38 in cell regulation is unknown, 
but one study identifies p53 ubiquitination. Previously, the orthogonal UB transfer (OUT) 
cascade with xUB~xE1 and xE1~xE2 pairs is used to determine xE2-xE3 pair. The current 
project focuses on generating RNF38 Ring domain libraries with the randomization of four key 
residues in the E2-binding site then selecting out specific xE2-xRNF38 RING pairs allowing 
exclusive transfer of xUB to substrate proteins of RNF38. RNF38 RING library is displayed on 
the surface of M13 phage for the selection of RING mutants binding with xE2. After identifying 
functional xE2-xRNF38 pairs, xRNF38 is used to assemble the OUT cascade to identify 
potential substrates by proteomics. 
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INTRODUCTION 
1.1 Background Information 
1.1.1 Ubiquitin Signaling Pathway 
 The ubiquitin cascade is a highly regulated process within cells targeting proteins for 
post-translational modification with ubiquitin (UB).1 Proteins modified with UB are thought to 
signal for degradation, but non-degradation pathways can occur after ubiquitin modification.2-3 
Ubiquitinated protein substrates can respond differently within the cell depending on the number 
and where UB modifications occur on the substrate.4-10 UB signaling is still under study, but new 
advances will help elucidate pieces of the signal pathway. 
 The UB cascade is transfers uses three enzymes to transfer UB through thioester linkages 
before forming an amide linkage with specific substrates (Figure 1.1). UB activating enzymes 
(E1) activate UB with adenosine triphosphate (ATP) through nucleophilic attack of the oxyanion 
from C-terminal carboxyl group to the α-phosphate in a two-step manner to release a 
pyrophosphate and form UB-AMP conjugate allowing for nucleophilic attack from a reactive 
cysteine thiol on E1 onto the C-terminal carboxyl group of ubiquitin and release AMP.11 The 
UB~E1 conjugate interacts with the UB conjugating enzymes (E2) within the ubiquitin fold 
domain (UFD) of E1 where nucleophilic attack of E2’s reactive cysteine thiol onto the C-
terminal carboxyl group of UB form a thioester intermediate.12 The UB~E2 conjugate interacts 
with the E2 binding domain of ubiquitin ligase (E3) before the substrate associates with the 
substrate binding domain of E3 to undergo UB modification. E3s are categorized into three 
major class types, HECT-type, RING-type, and RBR-type, via their interaction with E2 and the 
substrate. HECT E3s directly have UB transferred by nucleophilic attack from a reactive cysteine 
residue, then interact with the substrate for the final transfer of ubiquitin (Figure 1.1 arrow a).13 
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RBR E3s, such as Parkin and HHARI, have the two RING domains with a linker in between, but 
RING2 has a catalytic cysteine residue which will behave similarly to HECT-type E3s. 14 RING 
E3s act as scaffolds to transfer UB to the substrate from the E2-UB conjugate when the substrate 
is close in proximity (Figure 1.1 arrow b). In most cases, UB is transferred to the ε-amino group 
of lysine residue(s) of the substrate, but in rare cases the α-amino group can be ubiquitinated.15-16 
In the absence of the substrate, E3s will undergo autoubiquitination, where multiple UBs 
conjugate onto the E3 lysine residue and signal E3s for degradation in a regulatory event to 
control UB cascade.17  
Figure 1.1 UB cascade with RING/ U-box and HECT E3 ligases 
Ubiquitin (UB) associates with the adenylation domain (AD) of E1 and ATP associates with 
ATP-binding site. UB is activated through nucleophilic attack of C-terminal carboxyl group 
on ATP allowing nucleophilic attack of catalytic cysteine residue on E1. E2 associates with 
ubiquitin fold domain (UFD) of E1 and uses catalytic cysteine to attack UB at C-terminal. 
Two paths are presented between HECT (path a) and RING/ U-box (path b) E3s based on 
whether the ubiquitination on the substrate occurs directly or indirectly from the type of E3. 
Substrate will be polyubiquitinated and signaled for protein degradation by 26S proteasome. 
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1.1.2 Challenges with Studying UB Substrates 
Studying the ubiquitin cascade has its challenges identifying E2-E3 and E3-UB pairs 
(Figure 1.2). The main issue is studying each interaction separately to understand and identify 
potential substrates. Currently only a few E1s, dozens of E2s, and several hundred E3s have been 
identified.18 Multiple cross-reactivities occur between E1-E2, E2-E3, and E3-substrate pairs, 
therefore, complicating identification. Another difficultly in understanding the UB cascade is the 
multiple lysine residues on ubiquitin which can alter the chain linkages (Figure 1.3). Ubiquitin 
itself has multiple lysine residues (K6, K11, K27, K29, K33, K48, and K63) which can react 
with C-terminal carboxyl groups on ubiquitin to form linear chains and branched linkages.19-26 
Ubiquitin chains can be homotypic, the chains and linkages are formed via the same lysine 
residue, and heterotypic, the chains and linkages are formed with different lysine residues.27-29 
Figure 1.2 Cross reactivity within the ubiquitin cascade 
 The complexity in the ubiquitin cascade makes it difficult to identify substrates of 
ubiquitin ligases. Enzymes within UB signaling are promiscuous where a substrate can 
be ubiquitinated by multiple E3s and there are multiple E2-E3 pairs for a specific E3. 
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The different chains and linkages with UB lysine residues are reported to serve as signals for 
different functions within the cell.4-6 Linear chains of K48 are commonly seen to signal for the 
degradation by the 26S proteasome, but linear K11 and K29 chains have also been reported to 
signal for degradation.30-31 Recently, there are cases of ubiquitination on histones to serve as 
epigenetic markers.32  
Figure 1.3 Modes of ubiquitination and chain linkages 
 Ubiquitin protein has seven lysine residues used as markers for different signaling 
pathways. The substrate can be monoubiquitinated (single ubiquitin), 
polyubiquitinated (ubiquitin chain at a single site on substrate), or 
multiubiquitinated (ubiquitin at multiple sites on substrate). Polyubiquitination can 
be further categorized into homotypic or heterotypic linkages. Homotypic linkages 
use the same Lys residue (K48 or K63) or C-terminus of one UB and N-terminus of 
another UB (linear M-1) to form the chain. Heterotypic linkages use different Lys 
residues to form a chain or form a branched linkage forming two differing chains. 
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Several techniques have been used to determine potential substrates of E3s as well as 
classification of E3s. One technique takes advantage of ubiquitinated protein substrates by using 
antibodies (Abs) targeting the diGly fragment after the substrates undergo trypsin digestion. 
Additionally, the use of stable isotope labeling of amino acids in cell culture (SILAC) with diGly 
antibodies allows for identifying ubiquitinated substrates as well as which lysine residues get 
modified.36 Another method uses the diGly fragments for ubiquitylation mapping with mass 
spectrometry after using proteasome inhibitor or deubiquitinating enzymes (DUBs).37-39 Such 
techniques have been employed to identify culin-RING E3s, the CRL family, and ubiquitin-like 
(UBL) protein, NEDD8.40 Substrates can be determined via their interaction with the E3 and 
categorizing the interacting domain help elucidate a substrate’s E3 counterpart.41 Microarrays 
also have been used to identify potential substrates and E3s in vitro.42 Electrochemiluminescence 
Figure 1.4RNF38 RING Crystal Structure 
(A) Cartoon representation of RNF38 RING (blue) with two loop regions interacting 
with Zn2+ ions (grey). The two loops chelating the Zn2+ ions are characteristic of 
RING-type E3s similar to zinc-finger motifs. (B) Interface of RNF38 RING domain 
with UbcH5B and UB. Cartoon representation of RNF38 RING domain (blue), 
ubiquitin (yellow), and UbcH5b (green) with two spherical representations of Zn2+ 
ions. Crystal structure, PDB: 4V3L, for this complex was identified by Buetow, L. et 
al. 2015.63 
UB 
RING 
RNF38 UbcH5b 
A B 
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helps elucidate E3s after undergoing polyubiquitination from specific E2s on multi-array 
assays.43  
Current techniques to identify E3s and substrates have drawbacks which may hinder the 
study of UB signaling. Overexpression of E3s can ultimately decrease overall activity while in 
vivo during the process of collecting the cells, thus no change in ubiquitination of the substrate 
may be observed. Techniques involving diGly Abs are useful for substrate identification and 
multi- or poly ubiquitination chains, but the only the substrates can be identified. Therefore, the 
E3s in the pathway are not known leaving a mystery as to which E3 ubiquitinates the substrate. 
The technique for using the type of interactions to identify substrates with E3s is extremely labor 
intensive as well as some E3s within large families have conserved domains, but the substrates 
could be very different or similar. Screening methods which rely on affinity towards E3s do not 
result in actual biological activity within the UB cascade. Lastly, in vitro experiments occur 
under highly controlled conditions, but do not represent how the enzymes may function in vivo. 
New strategies to help solve these complications are still being pursued to determine the 
substrates of E3s and which interactions are present throughout a single ubiquitin cascade from 
UB transferred to substrate. 
1.1.3 Rationale in Studying RING E3s 
The RING family make up a majority of the identified E3 enzymes which are regulated 
in several biological signaling pathways.44-50 Identification of the E3s responsible in substrate 
ubiquitination will aid in determining potential causes for a variety of diseases. A few of the 
RING E3s identified are known to be involved in the development or suppression in a variety of 
different diseases.51-56 RING E3s are classified based on the highly conserved RING domain 
involved in activity as an E3 ligase.57 
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 RING finger proteins dominate the class of E3s, and as previously stated, they lack a 
catalytic cysteine to directly transfer UB to the substrate. RING finger proteins have a unique 
zinc-binding motif with either cysteine or histidine in the first few residues of the RING.58 The 
zinc ions help maintain the structural integrity and activity for the RING domain. The zinc 
coordination pattern is distinct between the classes of E3s RING-type, and RING-type E3s act as 
a scaffold for the E2 to transfer the UB to the substrate.  
1.2 RNF38 
The E3 of interest is RING finger protein 38 (RNF38), a highly understudied E3 ligase. 
RNF38 is reported to function as a nuclear E3 ligase which ubiquitinates tumor suppressor 
protein, p53, and evidence supports the role of nuclear localization for p53 after being targeted 
for ubiquitination.59 Both structural and type of ubiquitination of RNF38 still remain elusive, thus 
Figure 1.5 E2-E3-UB interaction 
(A) Close-up of RNF38 RING domain-UbcH5B interaction with color scheme of side 
reside chains represented as sticks as follows: O atoms (red), S atoms (yellow), and N 
atoms (blue). Key residues are labeled. (B) Close-up of RNF38 RING domain-UbcH5B-
UB interaction with similar color scheme as (A). Hydrogen bonds are red dashed lines 
with labeled distances and grey spheres are Zn2+. Labeling scheme is as follows: RNF38 
RING (blue), UbcH5B (green), and UB (yellow). 
A B 
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complicating how this E3 acts in vivo. Similar RNF E3s have been identified, but their role is 
quite varied within several signal pathways.60-62 
A partial protein structure for RNF38 RING domain elucidates the protein interaction 
with E2, UbcH5B, and UB (Figure 1.4).63 RNF38 RING domain is composed of three β-strands 
in antiparallel configuration, two pairs of Cys residues interacting with two Zn2+ (not shown), an 
alpha helix, and several loop regions.63 One of the loops interacting with Zn2+ has an interaction 
with the n-terminal of the helix interaction with UbcH5B. The E2-binding domain from RNF38 
RING has hydrogen bond formation from Cys418 with K8 from UbcH5B (Figure 1.5 A) and 
potentially an electrostatic interaction of Asp419 from RNF38 RING and K8 from UbcH5B. 
 xE1 interacts with xUB-HA via mutated AD while wt-UB cannot associate due to 
charge reversal in AD. xE2 associates with the mutated UFD of xE1 to transfer xUB-
HA to the catalytic cysteine. wt-E2 cannot associate to UFD due to the charge 
reversal within the UFD. RING-type xE3 acts as a scaffold to allow transfer of xUB-
HA to the substrate from xE2. wt-E2 will not associate with mutated E2-binding 
domain of xE3 based on the charge reversal while the substrate binding domain for 
xE3 remains unchanged to allow the substrate to associate. 
Figure 1.6 OUT cascade 
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RNF38 RING domain interacts with UB and UbcH5b (Figure 1.5 B) with R454. R454 from the 
RING domain interacts with Q40 and R72 from UB as well as Q92 from UbcH5b.  
1.3 Orthogonal Ubiquitin Transfer Pathway 
 Previous research has developed bio-orthogonal cascade of engineered enzyme mutants 
known as orthogonal ubiquitin transfer (OUT).64 OUT clarifies a single pathway between the 
transfer of ubiquitin to the substrate by mutating key residues between the interactions of class of 
enzymes in the cascade (Figure 1.6) The engineered enzymes will not interact with their wild-
type counterparts; therefore, making this system highly useful to identify substrates for 
(A) wt-E1 has negative charges from aspartate or glutamate in both adenylation domain 
(AD) and ubiquitin fold domain (UFD), and UB associates with AD via positive charge by 
two arginine residues. (B) AD domain is mutated to reverse the charge by mutation of Asp 
or Glu to Arg or Lys rejecting wt-UB, therefore; mutant UB with charges reversed will 
associate to AD. AD mutated E1 is known as “forward E1” (fE1) while wt-E2 can associate 
with UFD. (C) Mutated UFD on E1 allows for wt-UB to associate to AD, but only mutant 
E2 (xE2) can associate to UFD. Mutated UFD E1 is known as “back E1” (bE1). (D) Both 
AD and UFD are mutated to have a complete charge reversal for E1 known as xE1. xUB and 
xE2 will associate to AD and UFD, respectively, on xE1 but wt-UB and wt-E2 cannot 
associate. 
A B C D 
Figure 1.7 Reversal of charge in the AD and/ or UFD of E1 
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engineered E3s. The OUT approach utilizes pairs based on their interface interactions, UB-E1, 
E1-E2, and E2-E3. Understanding these interface interactions allows for developing an 
interaction solely between engineered species, thus wild-type enzyme counterparts would not 
interfere.  
Two orthogonal pairs, engineered UB (xUB) with engineered E1 (xE1) and xE1 with 
engineered E2 (xE2), have already been identified.65 Studying the interaction between wild-type 
E1, Uba1, and UB the AD of E1 was a primary target where an electrostatic interaction between 
the positive charges of R42 and R72 on UB and Q576, S589, and D519 from the AD domain of 
Uba1.66 Therefore, through site-directed mutagenesis both sets of enzymes had a reversal of 
charges to generate an orthogonal pair. Uba1 also has a UFD necessary to interact with E2, and 
three negative charge residues, E1004, D1014, and E1016 are located within this domain.66 
Similarly a charge reversal for both the n-terminal helix on E2 and UFD on E1 would create the 
orthogonal pair. If only the UFD domain on E1 is mutated while the AD domain remains 
unchanged, then a partially mutated E1 exist, known as bE1 (Figure 1.7). If the AD domain is 
mutated while the UFD remains unchanged then a mutant E1 (fE1) is produced. When both AD 
and UFD domains are mutated then a fully engineered E1, xE1, will exist allowing for a 
complete the both xUB and engineered E2, xE2, to bind. The last factor for the orthogonal 
pathway is the generate a reactive engineered E3, xE3, to interact with xE2. Potential E3 mutants 
must be screened against xE2 to find reactive xE3s using a display system. Some common 
display systems use bacterial surface display67, yeast surface display68, and phage display69, but 
phage display is used almost exclusively for determination of potential xE3s by previous 
research70. 
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1.4 Phage Display and Library Selection 
 
1.4.1 M-13 Phage Display 
 The bacteriophage, M-13, is the display vector used for infection of F factor containing 
E. coli strains (XL1-blue) because M-13 phage is a member of the Ff class within the genus 
Inovirus bacteriophage uses E. coli’s F conjugative pilus for attactment.71 M-13 bacteriophage 
physiology is rod shaped with six capsid proteins surrounding a circular (+) single-stranded 
DNA (ssDNA) genome encoding for 11 proteins, pI-pXI (Figure 1.8 A).72-76 The lysogenic 
Figure 1.8 M-13 phage structure and display vector 
(A) Cartoon representation for the structure of M-13 phage. Circular (+) ssDNA (red) 
M-13 phage with rod-like capsid. Capsid proteins for structural and attachment: pIII 
(purple), pVI (orange), pVII (brown), pVIII (grey), and pIX (black). (B) Partial 
representation for the different types of pIII phagemid vectors. The notations are as 
follows: LacZ (LacZ operon), S.D. (shine-delgano), OmpA (signal peptide), pIII 
protein.  
A 
B 
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lifecycle of M-13 virion is beneficial for phage-displaying proteins as the viral genome is 
integrated into the host genome and plasmid DNA.72 Display methods for M-13 use phagemid 
vectors incorporating pIII are pComb3, pComb3X, pComb3H, and pJuFo where the pComb3H 
(pComb) vector is used in current research (Figure 1.8 B).80-83 pIII and pVIII are commonly used 
for display of proteins on the bacteriophage surface.77 pIII is the viral protein of interest for 
display with proteins fused to N-terminal end of pIII, but this results in slight reduction of 
infectivity.69,78 The use of a “helper phage” or wild-type M-13 phage helps kick start the 
phagemid, modified bacterial plasmid with pIII and gene fused to N-terminal.79-80  
1.4.2 Library Selection 
 Phage-displayed E3 will be selected out with a technique known as biopanning.84 
Biopanning is an affinity-based approach to select specific sequences from a large pool, like a 
library. Purified antigens which have been immobilized are used to select out antibody libraries 
displayed on phage.85 New advances to selection techniques have advanced since then allowing 
for antibodies to target antigens presented on the cell surface, known as cell panning.86 Another 
way is to post-translationally modify proteins by biotin-labelled reactants, an approach employed 
by previous research for ubiquitin signaling using biotin-labeled ubiquitin undergoing ubiquitin 
pathway onto E3-displayed phage to be pulled down by streptavidin-coated plates.65 Recently 
chemically modifying molecules with biotin has been shown to be very effective in selecting out 
sequences by using streptavidin coated plates.87 
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1.5   Purpose of the Study 
Here determining the xE2-xE3 pair with RNF38 for the OUT cascade is crucial before 
identifying potential substrates. First, the activity of wt-RNF38 RING with a GST tag is 
observed with autoubiquitination assay then p53 ubiquitination assay before insertion of the 
RNF38 RING domain within the pComb phagemid. Activity of the phage-displayed RNF38 
RING is observed to rule out RNF38-pIII fusion does not interfere with the autoubiquitination of 
RNF38 RING using the UB cascade. Phage-displayed E3 assays using both enzyme-linked 
immunosorbent assay (ELISA) with a direct immunoassay approach with primary antibody (1o 
Ab) targeting the pVIII protein of M13 phage (Figure 1.9) and targeting against the N-terminal 
tag of RNF38 RING with an immunoblot (IB). After confirming phage-displayed activity, the 
efficiency of the RNF38 RING-phage is compared with a control phage in a process known as 
Figure 1.9 ELISA for wt-E3-phage 
Cartoon representation of an ELISA with a direct immunoassay approach to determine E3-
phage display activity. Streptavidin-coated plates will bind biotin-tagged ubiquitin 
conjugated to E3-phage. Anti-M13 primary Ab conjugated with horseradish peroxidase 
(HRP) binds to pVIII protein of M13 phage. The oxidation reaction of TMB with H2O2 
catalyzed by HRP will allow for color-inducing intermediate resulting in a positive result. 
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model selection (Figure 1.10).64 Model selection uses variable ratios of of wt-E3-phage and 
control-phage using colony PCR to show efficiency of the E3-phage. Then   
 Construction of a 4-mutant library for possible RNF38 RING domain sequences will be a 
two-step process: first an alanine screen on the four mutants: L412, M417, C418, and D419, and 
second will be the randomization of these four residues to generate all possible sequence 
variations. The generation of the DNA construct will occur through overlap PCR and inserted 
into the pComb phagemid, then to be transformed into XL1-blue cells (Figure 1.11). The library 
will be displayed on M-13 phage similarly as was previously stated in the model selection 
process. The library selection process will undergo a pseudo-orthogonal pathway with bE1, xE2, 
and UB-Bio. As previously stated bE1 is the mutated UFD domain of E1 where UB interacts 
Figure 1.10 E3-phage Model Selection 
wt-E3 and Fab (control) are displayed on pIII protein of M-13 phage. wt-E3-
phage will undergo the ubiquitin pathway in vitro and set against varying ratios 
of control phage, then be pulled down by streptavidin coated wells. Bound E3-
phage will be eluted and infect XL1-blue cells then a colony PCR for verying 
ratios will determine the efficiency of E3-phage. 
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with the AD domain and N-terminal helix of xE2 interacts with UFD domain. Sequences from 
the RNF38 RING domain library will be selected out based on the interaction of the xE2 and E3 
library interface. Sequences are displayed on pIII and activity is tested in the OUT cascade with 
xUba1 (xE1), xUbcH5b (xE2), and HA-xUB. Sequences which are autoubiquitinated with HA-
xUB are termed engineered RNF38 RING (xRNF38 RING).64 xRNF38 RING sequences will be 
inserted into full-length RNF38 (FL-RNF38) for protein expression in HEK293 cells. Selected 
FL-RNF38 proteins will undergo autoubiquitination in the OUT pathway using xE1, xE2, 
Figure 1.11 Library construction and phage display 
Construction of the library for all possible sequences from four mutation sites is 
performed via overlap PCR. Initially up and down fragments are amplified 
which have a section of identical DNA, therefore both fragments can anneal to 
one another to generate a full-length insert. The insert is ligated into pComb 
phagemid and transformed via electroporation into Xl1-blue cells. The cells are 
grown on selective media specific for the resistance within the phagemid then 
pDNA of the library are purified from isolate colonies. The E3 library is 
displayed on the pIII viral protein of M-13 phage. 
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xRNF38 proteins with HA-xUB. Reactive xRNF38 will ubiquitinate the substrate, p53, in the 
OUT pathway in vitro to provide evidence for FL-xRNF38 targeting p53.59 
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2 Model Selection for wt-RNF38 
2.1 Introduction 
 Here wt-E3, RNF38 RING, is studied to confirm activity within the UB cascade in vitro 
before displaying on M-13 phage. First wt-RNF38 is inserted into pGex vector for expression in 
BL21 cells where RNF38 RING undergoes autoubiquitination in vitro then ubiquitination of the 
substrate, p53 in vitro to confirm activity of the RING domain. wt-RNF38 is inserted into the 
pComb phagemid where wt-RNF38 RING will be displayed onto the N-terminal end of pIII 
protein from M-13 phage. ELISA and autoubiquitination assay confirm activity of phage-
displayed RNF38 (refer to Figure 1.9). Model selection with 1:1, 1:10, and 1:100 wt-RNF38 
RING-phage: 7G12 control-phage confirm efficiency of the phage-displayed E3 (refer to Figure 
1.10).  
2.2 pGex vector and wt-RNF38 RING  
 
Figure 2.12pGex vector 
pGex vector with wt-RNF38 RING insert, H6 and GST tags, TEV recognition, 
ampicillin resistance gene, and BamHI and EcoRI restriction sites. 
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2.2.1 pGex vector 
Figure 2.213Sequence analysis of pGex-wt-RNF38 and RNF38 RING 
(A) Full length wt-RNF38 sequence overlapped together from pGex-FL1-
RNF38 and pGex-FL2-RNF38 with key features of TEV recognition, proline-
rich region and RING domain. (B) wt-RNF38 RING inserted into the pGex 
vector. Key features include TEV site, H6 tag and GST tags, and RNF38 RING. 
A 
B 
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 pGex vector is used as a protein expression vector for insertion of the FL-wt-RNF38 and 
wt-RNF38 RING (only RNF38 RING is included in study). pGex vector includes H6 
(HHHHHH) and GST tags, resistance gene, and TEV recognition site (Figure 2.1). pGex vector 
can be used for plasmid expression in XL1-blue cells, but protein expression for FL-RNF38 is 
reported to yield active protein with HEK293 cell line.59 However, only the RING domain will 
Figure 2.314Activity of GST-RNF38 RING protein 
A B 
C 
(A) Scheme for autoubiquitination of E3 RING domain with N-terminal GST tag. 
UB transfers to a lysine residue on E3 RING in the absence of a substrate. 
Polyubiquitin chain formation occurs in vitro without degradation of the E3 RING 
domain. (B) Coomassie staining for the expression of GST-RNF38 RING 
comparing the protein lysate with the GST elution showing a ~35 kDa band 
verifying GST-RNF38 RING. (C) Autoubiquitination of GST-RNF38 RING in 
vitro with Uba1, UbcH5B, GST-RNF38 RING, and HA-UB. Lanes from left to 
right: +, -Uba1, -UbcH5B, and -HA-UB. GST-RNF38 RING is identified at ~35 
kDa in IB: GST at 1 min exposure. Polyubiquitin chain is shown on GST-RNF38 
RING in the “+” reaction only when compared to three negative controls. 
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be fused with GST and expressed in BL21 cell line for overexpression. RNF38 RING insertion 
into the vector occurs with BamHI and EcoRI restricti on enzymes (REs). 
2.2.2 wt-RNF38 RING  
Genomic studies for FL-wt-RNF38 in humans have determined the coding sequence 
(1545 bp) from the translated sequence (515 aa).89 However the crystal structure and function for 
FL-RNF38 remains elusive, but only RING domain has been shown to have function and the 
sequence has two featured regions: proline-rich region and RING domain (Figure 2.2A). RNF38 
RING will be studied for activity with protein assay, model selection, and library selection. wt-
RNF38 RING is inserted into the pGex vector and sequence analysis confirms ligation of RING 
domain (Figure 2.2 B). The GST protein is fused with the N-terminal protein of RNF38 RING 
for protein purification and using GST tag as a marker to study whether RING domain only is 
active in UB cascade. pGex-RNF38 RING expression in BL21 cells will be tested for activity 
within UB cascade. 
Figure 2.415Substrate ubiquitination by RING domain 
B A 
(A) Scheme for substrate ubiquitination with E3 RING domain with N-terminal GST 
tag. UB transfers to a lysine residue on the substrate. The interaction of E2 with 
substrate will determine whether mono- or polyubiquitin chain formation occurs in 
vitro. (B) Substrate ubiquitination with p53 in vitro with Uba1, UbcH5B, GST-
RNF38 RING, and HA-UB. Lanes from left to right: +, -Uba1, -UbcH5B, -GST-
RNF38 RING, and -HA-UB. p53 is identified at ~53 kDa in IB: p53 at 1 min 
exposure. Polyubiquitin chain is shown on p53 in the “+” reaction only when 
compared to four negative controls. 
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2.3 wt-RNF38 RING Activity 
FL-RNF38 does not express well nor showed significant activity in BL21 or HEK293T 
cells, but GST-RNF38 RING domain is expressed well in BL21 cells.59,63 Expression of wt-
RNF38 RING in BL21 cells is purified with fusion of GST tag resulting a protein size of ~35 
kDa shown in the figure below (Figure 2.3 A). GST-RNF38 RING fusion protein yields ~71.2 
mg / mL with minimal impurities. A scheme for the autoubiquitination of E3 RINGs with N-
Figure 2.516pComb phagemid and pComb-wt-RNF38 RING sequence 
A 
C 
B 
(A) Plagemid of pComb with Fab, 7G12, insert, ampicillin resistance gene, 
pIII gene, SacI, SpeI, and ClaI restriction sites, and TEV recognition. (B) 
Phagemid of pComb with wt-RNF38 RING insert and addition of FLAG tag, 
SacII site. (C) wt-RNF38 RING inserted into the pComb vector. Key 
features include TEV site, FLAG tag, and pIII protein, and RNF38 RING. 
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terminal GST tag occurs in the absence of substrate (Figure 2.3 B). Autoubiquitination of GST-
RNF38 RING in IB: GST shows polyubiquitination in only the “+” reaction while no ubiquitin 
bands occurred in the three negative controls: -Uba1, -UbcH5B, and -HA-UB (Figure 2.3 C). 
Interestingly there is the appearance of a band ~70 kDa which may show GST-RNF38 RING 
exist as a dimer, but further evidence is required to prove dimeric activity. A scheme for 
substrate ubiquitination from E3 RING with GST tag occurs when E2~UB is proximal to the 
substrate after both substrate and E2 associate with E3 RING domain (Figure 2.4 A). GST-
RNF38 RING targets p53 after showing activity in p53 ubiquitination providing evidence that 
Figure 2.617wt-RNF38 RING-phage activity 
A 
C D 
B 
(A) wt-RNF38 phage display in anti-FLAG immunoblot. Lanes (left to right): Previous 
wt-RNF38-phage (10 days old) and freshly prepared wt-RNF38-phage with 60 sec. 
exposure time. (B) Scheme for autoubiquitination of E3 RING domain conjugated to N-
terminus of pIII on M-13 phage. (C) Autoubiquitination assay for wt-RNF38 RING-
phage with Uba1, UbcH5B, wt-RNF38 RING-phage, and Bio-UB in IB: FLAG with 
exposure time at 30 sec. Reactions left to right: “+”, -Uba1, -UbcH5B, and -Bio-UB are 
incubated overnight at 37oC. Polyubiquitin chain may interfere with the FLAG tag, thus 
preventing the 1o Ab against FLAG tag as the three negative controls show FLAG tag 
~30 kDa. (D) ELISA assay for activity of wt-RNF38 RING-phage activity using α-M-
13 phage 1o Ab-HRP conjugate. Positive reaction occurs in “+” reaction while no 
reaction occurred for three negative controls in 100 reactions, but not reactions are 
observed for 10-1 and 10-2 “+” reactions. 
23 
 
 
the RING domain associates with both UbcH5B and p53 (Figure 2.4 B). p53 ubiquitination 
occurs only in the “+” reaction when compared to four negative controls: -Uba1, -UbcH5B, -
GST-RNF38 RING, and -HA-UB. Surprisingly, p53 is shown to act as a dimer as a band ~100 
kDa occurs after a four-hour reaction (data not shown). The other bands present lower than p53 
may be a result of the 1o Ab binding to fragments of recombinant p53 which is shown on both 
commercial and expressed p53 (data not shown). 
2.4 wt-RNF38 RING-phage Activity 
2.4.1 pComb vector 
 pComb vector, as previously stated, is a phagemid with resistance gene, pIII protein from 
M-13 phage, and LacZ operon (Figure 2.5 A). A TEV recognition site: ENLYFQG is included 
right after the SpeI recognition sequence. TEV site will be further explained in chapter 4 when 
used in selection of RNF38 RING 4-mutant library. The 7G12 Fab insert (1410 bp) will be used 
as a control in the model selection with wt-RNF38 RING domain (Figure 2.5 B).88 pComb 
vectors will be optimal for male E. coli cells with F conjugative pilus for the helper phage to 
initiate infection, hence XL1-blue E. coli will be used to uptake phage.71 pComb phagemid 
includes an ampicillin resistance allowing XL1-blue cells to be selected out from natural 
resistance to tetracycline, but XL1-blue with pComb phagemid will grow in tetracycline/ 
ampicillin media. The RING domain is inserted into the pComb vector for phage display on pIII 
of M-13 phage. The template for the phagemid used in model selection, library construction, and 
library selection is shown below (Figure 2.5 C). The phagemid construct includes FLAG tag 
(DYKDDDD), SacI, SacII, SpeI, and ClaI REs, TEV recognition site, and pIII. 
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2.4.2 wt-E3-Phage Activity  
Native RNF38 RING domain is ensured to be displayed by M-13 phage before testing the 
efficiency of wt-RNF38 against 7G12 control. Phage-displayed wt-RNF38 is verified with IB: 
FLAG showing a ~30 kDa band (Figure 2.6 A). An indirect approach for IB ensures the efficacy 
of the 2o Ab binding to the 1o Ab, thus providing stronger and more accurate signal. wt-RNF38 
RING-pIII conjugate is ~30 kDa in size, but a slightly smaller band appearing less than 25 kDa 
was seen which a cleaved fragment or truncation of wt-RNF38 RING-pIII occurs in vivo during 
capsid protein expression and assembly for the M-13 virion. 7G12-phage does not appear in IB: 
FLAG due to the absence for the FLAG-tag in the sequence. Autoubiquitination of FLAG-
RNF38-RING-phage occurs similarly as autoubiquitination with GST-RNF38 RING in the 
scheme above to demonstrate phage-displayed proteins will not have have activity interference 
from the phage protein (Figure 2.6 B). Autoubiquitination of FLAG-RNF38 RING-phage shows 
evidence for activity of E3 RING displayed on pIII capsid protein (Figure 2.6 C). 
Polyubiquitination of FLAG-RNF38 RING-phage in the “+” reaction may affect the binding of 
α-FLAG 1o Ab by shielding the tag, but the three negative controls show only one band ~30 kDa 
indicating no autoubiquitination. An ELISA assay helps determine the sensitivity of phage-
displayed activity for FLAG-RNF38 RING-phage (Figure 2.6 D). A positive result occurs in the 
“+” reaction indicating E3 RING-phage has Bio-UB conjugated to a lysine residue, thus α-M-13 
phage 1o Ab-HRP conjugate is able to bind and oxidize TMB substrate in the presence of H2O2. 
There is no reaction observed for the three negative controls. Unfortunately, only 100 reaction 
produces a positive result while 10-1 and 10-2 reactions do not show activity. 
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2.5 wt-E3-phage Model Selection 
The titer for 7G12- and wt-RNF38 RING- phage, respectively, are 5.4 x 107 pfus and 5 x 
109 pfu resulting a in 100-fold decrease and would make the model selection parameters more 
difficult to obtain. 7G12-phage is prepared once more to provide a better phage titer to be near 
wt-RNF38 RING-phage yielding a titer of 1.3 x 109 cfus (data not shown). Reactions for the 
ELISA and model selection have a total wt-RNF38-phage concentration of 9 x 1010 pfu while 
7G12-phage is varied for 1:1, 1:10, and 1:100 wt-RNF38-phage: 7G12-phage. Colony PCR with 
primers, Jun13 and Jun14 (refer to Table 3.1), tests the efficiency of RNF38 RING-phage: 
7G12-phage 1:1, 1:10, and 1:100 ratios (Figure 2.7). All eight isolates in 1:1 reactions 
correspond to the RNF38 RING with ~500 bp band. In 1:10, isolates 1-3 and 5-7 (75% 
efficiency) are wt-RNF38 RING compared to 7G12, but isolates 1 and 8 have slight competition 
Figure 2.718Model Selection of wt-RNF38 RING. 
Colony PCR of isolate colonies with phagemid primers, Jun13 and Jun14, in 
ratios (1:1, 1:10, and 1:100) of wt-RNF38-phage: 7G12-phage. RNF38 RING 
domain is 500 bp band while 7G12 is 1500 bp band. wt-RNF38 RING-phage is 
effective in phage activity appearing in 6 of 8 isolates in 1:10 reaction and 1 of 8 
within the 1:100 reaction. 
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with 7G12. In 1:100, isolates 1-8 are 7G12 while isolates 1-7 have slight competition of wt-
RNF38 RING. 
2.6 Discussion 
RNF38 RING Sequence analysis for FL-RNF38 was spliced together from two-part 
sequence with an overlap within the proline rich domain (refer to Figure 2.2). 
Autoubiquitination for GST-RNF38 RING provides evidence of the RING domain only and does 
not provide data on how FL-RNF38 will undergo autoubiquitination. The ~70 kDa band present 
for autoubiquitination may elucidate GST-RNF38 RING dimeric activity only, but further assays 
are required to explore whether FL-RNF38 may exhibit dimeric activity. Ubiquitination of p53 
shows polyubiquitination in vitro as there is no regulatory signal for monoubiquitinating p53. 
When introducing RNF38 RING into the pComb phagemid, OmpA leader sequence is attached 
to the N-terminus of RING domain and directs the FLAG-tagged wt-RNF38 RING-pIII 
conjugate to the Sec pathway in E. coli to translocate the protein from the cytosol to the 
periplasm for assembly of the M13 virion.90-91 RNF38 RING-phage activity is not affected by 
being displayed on the N-terminus of pIII capsid protein suggesting little interference of the 
virion with the E3.  
2.7 Experimental Procedure 
2.7.1 Cloning of pGex-FL-RNF38 and RNF38 RING 
 wt-FL-RNF38 and wt-RNF38 RING (sequenced and prepared by previous lab member, 
Li Zhou) is inserted into pGex vector (previous construct provided by previous lab member, Li 
Zhou) with H6 and GST tag. pGex vector was purchased from Addgene.  
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2.7.2 Expression and purification of GST-RNF38 RING 
 Transformation with 2 μL of pGex-RNF38 RING plasmid into 50μL BL21 cells via 
electroporation is treated immediately with 1 mL SOC media and incubated for 1 hour in 37oC 
shaker. 50 μL of the solution is streaked onto 2% glucose ampicillin plates and incubated 
overnight in 37oC incubator. The remaining 950 μL is transferred to 200 mL 2XYT media with 
100 μg/mL ampicillin incubating overnight in a 37oC shaker. The cells are measured at O.D.600 
to be ~0.7-0.8 before transferring to 800 μL 2XYT media with 50 μM ZnCl2 and 100 μg/ mL 
ampicillin and incubated in 37oC shaker until O.D.600 measures ~1.2. The cells are cooled in 
20oC shaker for 20 min before inducing cells with 1 mL of 1M IPTG overnight in 20oC shaker. 
Cells are transferred to large centrifuge tubes and centrifuged at 5500 rpm for 15 minutes at 4oC. 
The supernatant is discarded while the pellet is resuspended in 40 mL of GST lysis buffer (pH 
8.8, 20 mM Tris, 500 mM NaCl, 0.1% Triton X-100, 10% glycerol, 10 mM DTT, 50 μM ZnCl2, 
1 mM PMSF, and 1 mM benzamidine). Lysozyme (1 mg/ mL) and 1 protease inhibitor tablet are 
added to resuspended pellet, mixed by inversion, and incubated on ice for 1 hour. Lysis mixture 
is sonicated at 19% for 30 mins with 10 s on / 10 s off. Lysate is transferred to ultracentrifuge 
tubes and centrifuged at 12,000 rpm for 30 min at 4oC. Glutathione-agarose beads were washed 
with 50 mL GST wash buffer (pH 8.8, 20 mM Tris, 500 mM NaCl, 10% glycerol, 10 mM DTT, 
1 mM PMSF, and 1 mM benzamidine) then centrifuged at 2,200 rpm for 5 min at 4oC while the 
supernatant is discarded. Gluathione-agarose beads were resuspended in protein lysate before 
incubating at 4oC on orbital shaker overnight. Lysate is run through protein column and collected 
in 50 mL tube. Beads are washed with 15 mL GST lysis buffer and collected in 15 mL tube. 
Beads are washed twice with 15 mL GST wash buffer and collected separately in 15 mL tubes. 
Beads are eluted with 6 mL GST elution buffer (pH 8.8, 30 mM reduced glutathione, 50 mM 
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Tris, and 150 mM NaCl) and dialyzed in GST dialysis buffer (pH 8.8, 50 mM Tris, 150 mM 
NaCl, 50 μM ZnCl2, 10% glycerol, and 10 mM DTT) overnight. The solution is concentrated in 
30 kDa protein centrifuge column and stored in -80oC freezer. An aliquot of 25 µL was collected 
from protein lysate and GST-elution fractions and mixed with 2X Lamelli with BME loading 
dye, boiled for 5 minutes, then spun down before electrophoresis at 200V for 30 min. in precast 
4-15% SDS-PAGE gel. GST-RNF38 RING is verified following Coomassie stain protocol. 
Bradford Protein Assay protocol was followed to determine protein concentration in 1 cm 
cuvette with Genesys20 spectrophotometer. Concentration was determined using equation 
(determined by previous lab member following Bradford Protein Assay protocol): (A595 + 
0.0245)/ 0.03945 * 0.8 μL sample (1:1 dilution factor) = mg/ mL). GST-RNF38 RING 
concentration (mg/ mL) is multiplied by following equation to determine μM concentration: 1 / 
35 kDa GST-RNF38 RING * 1000 μM / 1 mM * (concentrated mL / 1 mL) = μM. 
2.7.3 Ubiquitination Assays with wt-RNF38 RING and p53 
 Auto-ubiquitination for wt-RNF38 RING was conducted in 50 μL reactions with E1, 
Uba1 (1 μM), E2, UbcH5B (10 μM), E3, wt-RNF38 RING (5 μM), HA-UB (40 μM), ATP pH 
7.6 (5 μM), 1 X Tris HCl / MgCl2, 0.1 mM DTT, and remaining volume with diH2O. Three 
controls: -E1, -E2, and -UB are also conducted to serve as negative controls for auto-
ubiquitination. Reactions were incubated at 2 h in 37oC shaker then half of the reactions were 
stopped in 2X Lamelli with BME loading dye while the other half continued for 2 additional 
hours. The reactions for 4 h were stopped in 2X Lamelli with BME loading dye. Reactions were 
run following similar conditions as the western blot for wt-RNF38 phage with 1: 1500 α-GST 1o 
Ab and 1: 10000 α-mouse-HRP conjugate 2o Ab. 
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Substrate ubiquitination for p53 was conducted in 60 μL reactions with E1: Uba1 (1 μM), 
E2: UbcH5B (10 μM), E3: wt-RNF38 RING (5 μM), HA-UB (40 μM), p53 (Thermo Fischer) (5 
μM), ATP, pH 7.6 (5 μM), 1 X Tris HCl / MgCl2, DTT (0.1 mM), and remaining volume with 
diH2O. Three controls: -E1, -E2, and -UB are also conducted to serve as negative controls for 
self-ubiquitination. Reactions were incubated at 2 h in 37oC shaker before 25 μL of the reactions 
were stopped in 2X Lamelli BME loading dye. The remaining 25 μL incubated for 4 h before 
being stopped with 2X Lamelli BME loading dye. Reactions were run following similar 
conditions as the western blot for wt-RNF38 phage with 1: 1500 α-GST and 1: 1500 α-p53 1o Ab 
and 1: 10000 α-mouse-HRP conjugate 2o Ab. 
2.7.4 Cloning pComb-RNF38 RING and pComb-7G12 
 pComb vector was purchased from Addgene, but the pComb-wt-RNF38 RING construct 
was provided by previous lab member. FAB, 7G12, was inserted with SacI and SpeI REs into 
pComb vector. 7G12 Fab Ab was designed and purified by Dr. Andrea Cochran. 
2.7.5 wt-RNF38 RING phage display 
 Previously wt-RNF38 was purified and ligated to pComb vector to be used for selecting 
the efficiency of wt-RNF38-phage compared to 7G12- phage. pComb-wtRNF38 plasmid was 
transformed into commercial XL1-Blue cells via electroporation method, and streak plated 50 µL 
of inoculum onto 2% glucose, 100 µg/ mL ampicillin agar plates then incubated overnight in 
37oC incubator. Isolate colony was incubated in 10 µg/ mL tetracycline, 2XYT media for 12-15 
hours at 37oC. 2 mL of cell culture was pipetted to 20 mL solution containing 100 µg/ mL 
ampicillin, 2% glucose, and 2XYT media then incubated in 37oC shaker for 4-6 hours until O.D. 
was 0.7-0.8 via spectrophotometer. Cells were infected with 20 µL VCSM13 helper phage for 1 
hour in 37oC shaker then cells well centrifuged at 3700 rpm at 4oC for 12 min. The supernatant 
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was decanted while the cell pellet was resuspended in 200 mL 2XYT media with 70 µg/ mL 
kanamycin and 100 µg/mL ampicillin and incubated in 30oC shaker overnight. Cells were 
transferred to large sterile centrifuge tubes to be centrifuged at 5000 rpm for 12 min. at 4oC. The 
supernatant was transferred to another larger centrifuge tube with 38 mL of 5X PEG, mixed, and 
solution was incubated on ice for 1 hour. The solution was centrifuged at 5000 rpm for 1.5 hours 
at 4oC, decanted the supernatant, and resuspended the pellet in 3 mL 1X TBS pH 7.6 buffer. 
Resuspension was centrifuged at 13000 rpm for 10 min at 4oC, supernatant was transferred to 
chilled 1.5 mL tubes and stored in 4oC. 
2.7.6 Western Blot and Phage Titer 
 wtRNF38-phage was denatured in 20 μL 2X Lamelli w/ BME loading dye and boiled for 
5 minutes, then spun down before adding 9 µL of each reaction to precast 4-15% SDS-PAGE gel 
running at 200 V for 30 minutes. The nitrocellulose membrane was pre-soaked in methanol 
before transferring to 1X Transfer Blot Buffer. The gel was soaked in Transfer Buffer along with 
the filter papers, and then stacked in a cast for transferring the gel to membrane running for 10 
minutes at 25 V. The membrane was incubated for 1 hour in 5% milk in 1X TBS buffer. The 
membrane was sealed in pouch with 2000-fold dilution of anti-FLAG Ab (purchased from Sigma 
Aldrich) in 5% milk solution and incubated overnight on rotary shaker in 4oC. The membrane 
was washed thrice at 10-minute intervals with 1X TBS buffer, then was added to 20 mL of 5% 
milk with 5000-fold dilution anti-mouse-HRP conjugate Ab (purchased from Santa Cruz 
Biotechnology) and incubated at 25oC for 1-2 hours before being washed thrice at 10-minute 
intervals with 1X TBS buffer, and finally was subjected to 1 mL of Super Signal Pico Solution 
and 1 mL Super Signal Peroxide Solution and incubated for 5 minutes at 25oC. Film was 
developed for 1, 3, 5-min in a dark room.  
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wt-RNF38-phage and 7G12-phage conjugates were diluted to 10-6 by 1000-fold dilution 
in 1 mL of 1X PBS Buffer, pH 7.6, then 1000-fold dilution into 1 mL XL1-blue cell culture with 
O.D. ~0.7 in 10 µg/ mL tetracycline 2XYT solution. The cells infected by RNF38 RING-phage 
were incubated for 1 hour before serial dilution in 2XYT media. 5 μL of the serial dilutions are 
pipetted onto 2% glucose, 100 μg/ mL ampicillin agar plates in triplicate and incubated in 37oC 
overnight. Isolate colonies were counted to provide accurate titers. 
2.7.7 Autoubiquitination of RNF38 RING-phage and ELISA  
 Autoubiquitination for wt-RNF38 RING-phage was prepared similarly to 
autoubiquitination of GST-RNF38 RING except with 1x1010 pfus for phage concentration. 
 The ELISA assay was prepared in 100 μL reactions with Uba1 (1μM), UbcH5B (10 μM), 
wt-RNF38 RING-phage (1 x 1010 pfu), wt-UB-Biotin (Boston Biochem) (0.5 μM), ATP pH 7.5 
(5 μM), 1X Tris pH 7.5 HCl / MgCl2 Solution, 0.1 mM DTT, remaining volume with diH2O. 
Three negative controls with -E1, -E2, and -UB-Bio were prepared similarly. Reactions were 
incubated for 2 h in the 37oC shaker, then reactions were bound to the streptavidin-coated wells 
with 1:1 reaction: 3% BSA in 1X TBS-T incubating for 1 h on orbital shaker. Wells were washed 
20 times with TBS-T buffer and incubated for 1 h at room temperature with 100 μL BSA with 
20,000-fold dilution anti-M13 phage antibody (Fischer Scientific). Each well was washed 20 
times with 1 X PBS buffer, and mixed with 1:1 peroxide solution: TMB substrate for 5 minutes 
at room temperature. 
2.7.8 RNF38 RING model phage selection 
 wt-RNF38 RING-phage: 7G12-phage reactions were incubated in 1 mL of XL1 blue cell 
cultures (O.D. ~0.7) for 1 hour in 37oC shaker. Cell cultures were streaked onto 2% glucose, 100 
μg/ mL ampicillin plates incubating overnight in 37oC incubator. Colony PCR for eight isolate 
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colonies from 1:1, 1:10, and 1:100 plates was set up in 20 μL reactions with 0.5 nM Jun13 (5’- 
ACTTTATGCTTCCGGCTCGTATGT -3’) (primers from IDT) and 0.5 nM Jun14 (5’-
AATCAAAATCACCGGAACCAGAGC-3’), 2X DreamTaq Green PCR Master Mix (Thermo Fischer), 
and remaining volume with diH2O for RNF38 RING-phage: 7G12-phage with thermocycler 
conditions: 95oC for 2:00, (95oC for 30 s, annealing at 52oC for 30 s, extending at 72oC for 45 s 
for 35 cycles), 72oC for 4:00 min, and holding @ 4oC. The PCR products were verified in 1% 
agarose gel running for 35 min at 150 V with 1 µg of 1.0 kb DNA ladder and 20 µL of 1:1, 1:10, 
1:00 reactions were loaded into the corresponding wells.  
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3 RNF38 RING Library Construction 
3.1 Introduction 
 Characterization of conserved residues among RING E3s elucidate key residues within 
the RING domain responsible for interacting with E2. A library will be generated to cover all 
possible sequences to later be selected out when using xUbcH5B where K4E and K8E mutations 
are present on the N-terminal helix.92 An alanine screen is used to test potential primers to 
generate two fragments, upstream fragment and downstream fragment, for overlap polymerase 
chain reaction (PCR) (refer to Figure 1.11). RNF38 RING AAAA-mutant overlap insert for 
alanine screen is inserted into pComb vector after digestion, transformed into XL1-blue cells, 
and sequences are analyzed. RNF38 RING AAAA-mutant is used as a template for the 4-mutant 
library by randomizing the four alanine sites. 
3.2 Library Design  
 The interface of UbcH5B and wt-RNF38 RING shows hydrogen bonding between 
carbonyl on the backbone, located on an N-terminal loop containing Cys413 and Cys416 
chelating Zn2+, of RNF38 RING with K8 located on a N-terminal helix of UbcH5B (Figure 3.1 
A). Residues: L412, M417, C418, and D419 are targeted as these positions flank Cys413 and 
Cys416. The four residues are close to the N-terminal helix from UbcH5B which may interact 
intra- or intermolecular to stabilize the binding interface. The tight loop seems to be necessary to 
allow for hydrogen bond formation. This crystal structure provides only a small piece of 
evidence since a great deal of flexibility would achieve a potential electrostatic interaction 
between D419 of RNF38 RING and K8 of UbcH5B as well as a two hydrogen bonds form by 
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Figure 3.19E2-E3 Interface and E3 RING domain alignment of RING E3s 
(A) Interface of E2-binding domain of wt-RNF38 RING with N-terminal helix of 
UbcH5B. Residues for structural integrity and E2-E3 binding interface are labeled with 
hydrogen bond distance (Å). Blue labels represent basic residues while red labels are 
acidic residues. Mutations for xUbcH5B are included to determine new interface for 
xE2-xE3 at the E2 binding domain. (B) Alignment of translated RING E3s based on 
RING domain truncated to analyze conserved residues (shaded in black) to elucidate 
similarities for E2 binding interface. RING E3s have CXXC domain crucial for Zn2+ 
binding and residues near this motif interact with E2s. 
A 
B 
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 both carbonyl groups of Val414 and Val415 from RNF38 RING with Arg5 from UbcH5B.  
Several RNF E3s RING domains are aligned to show conserved residues within the RING 
domain which may interact with their respective E2s (Figure 3.1 B). The CXXC moiety is 
conserved among several RING-type E3s and residues neighboring will interact with N-terminal 
helix from E2. Randomization of four neighboring residues: L412, M417, C418, and D419 from 
RNF38 RING domain around the CVVC moiety will allow for interaction with xUbcH5B. 
Figure 3.20pComb-RNF38 RING alanine mutants 
(A) PCR of up and down fragments from RNF38 RING AAAA mutant. Lanes from left to 
right: 1.0 kb DNA ladder, RNF38 RING AAAA mutant upstream fragment, and RNF38 
RING AAAA mutant downstream fragment. (B) Overlap PCR of RNF38-AAAA mutant 
show ~250 bp band consistent with the overall size of the RING domain. (C) pComb-
wtRNF38 digestion with SacII and SpeI REs resulting in 3.0 kb band and ~250 bp band, 
respectively. (D) RNF38 RING-AAAA mutant digestion with SacII and SpeI with ~250 
bp band. (E) Ligation of pComb-RNF38 RING AAAA mutant in 1:3 ligation of SacII/ 
SpeI digested pComb phagemid: SacII/ SpeI RNF38 RING AAAA mutant insert in 
comparison with vector-only control. Effective ligation is determined by at least 10-fold 
difference in colony forming units (cfus) between control and ligation reaction. 
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3.3 RNF38 RING AAAA mutant construction 
 pComb-RNF38 RING (refer to Figure 2.5 C) is used as a template while primers 
included L412A, M417A, C418A, and D419A mutations. As previously stated with overlap 
PCR, an upstream fragment including a SacII restriction site and a downstream fragment 
consisting of four alanine mutations and SpeI restriction site are amplified. There is an area on 
the fragments, ~28 bp overlap near the 3’ end on the upstream fragment and the 5’ end of the 
downstream fragment, where the upstream fragment and downstream fragment will anneal, and 
extension of the fragments will produce a ~250 bp fragment (Figure 3.2 A & B). Digestion for 
Figure 3.321pComb-RNF38 RING 4-mutant library 
(A) PCR of up and down fragments from RNF38 RING 4-mutant library. Lanes from left 
to right: RNF38 RING AAAA mutant upstream fragment, 1.0 kb DNA ladder, and 
RNF38 RING AAAA mutant downstream fragment. (B) Overlap PCR of RNF38-AAAA 
mutant shows ~520 bp band consistent with the overall size of the RING domain as well 
as ~350 bp band in higher with more intensity. (C) pComb-7G12 digestion with SacI and 
ClaI REs result in 3.0 kb band and ~1500 bp band, respectively. (D) RNF38 RING 4-
mutant library digestion with SacI and ClaI with ~520 bp band as well as the ~350 bp 
band. (E) Ligation of pComb-RNF38 RING 4-mutant library in 1:10 ligation of SacI/ 
ClaI digested pComb phagemid to SacI/ ClaI RNF38 RING 4-mutant library insert in 
comparison with vector-only control. Effective ligation is determined by at least 10-fold 
difference in colony forming units (cfus) between control and ligation reaction. 
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pComb-RNF38 RING and RNF38 RING AAAA mutant occurs with restriction enzymes (REs), 
SacII and SpeI (Figure 3.2 C & D). The pComb-wt-RNF38 RING did not have complete 
digestion as verified by the low intensity of the ~250 bp band which may affect ligation of 
RNF38 RING AAAA mutant into pComb phagemid. Though the digestion did not provide 
complete digestion, ligation of pComb-RNF38 RING AAAA mutant yields many colony 
forming units (cfus) when compared to digested pComb phage only (Figure 3.2 E). Sequence 
analysis from four of six isolate colonies confirm L412A, M417A, C418A, and D419A 
mutations. 
3.4 RNF38 RING 4-mutant library construction 
 Construction of RNF38 RING 4-mutant library is generated from RNF38 RING AAAA-
mutant template similar to alanine mutant construction except that the four mutation sites use 
NNK sequence to represent twenty amino acid combinations. The upstream fragment includes 
SacI restriction site with FLAG tag while the downstream fragment includes four NNK 
sequences, ClaI restriction site, pIII protein and TEV recognition site (Figure 3.3 A). The 
overlap of upstream and downstream fragments occurs in the similar region as the alanine mutant 
insert but yields a larger band ~520 bp (Figure 3.3 B). The 4-mutant library insert is repeated 
multiple times to achieve at least 100-150 µg before digestion. pComb-7G12 and RNF38 RING 
4-mutant library are digested with SacI and ClaI (Figure 3.3 C & D). pComb-7G12 is almost 
completely digested as the band intensities are similar from a qualitative perspective where 7G12 
is verified by ~1500 bp band. The 4-mutant library after digestion yields intense bands ~520 bp 
and ~350 bp suggesting that many of the fragments could not have undergone overlap PCR as 
effectively as alanine mutant insert (Figure 3.3 D). Ligation of pComb-RNF38 RING 4-mutant 
library yields a 10~fold increase of SacI/ ClaI digested pComb with SacI/ ClaI digested 4-mutant 
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library in a 1:10 ratio, respectively, when compared to digested pComb-only (Figure 3.3 E). The 
relatively low amount of cfus present in the 1:10 ligation could be the result of the downstream 
fragment being amplified in excess while less intensity is observed for the ~520 bp band. 
 The ligation for pComb-RNF38 RING 4-mutant library is verified through colony PCR 
for twelve isolate colonies with primers, Jun13 and Jun14 (refer to Table 3.1). The primers 
Figure 3.422RNF38 RING 4-mutant library 
(A) Colony PCR with primers, Jun13 and Jun14, on twelve isolate colonies of pComb-
RNF38 RING 4-mutant library. A ~500 bp band includes OmpA leader sequence, 
RNF38 RING domain sequence, and pIII sequence.  (B) Library titer comparing all 
possible sequences for a 4-mutant library with the number of potential cfus generated 
in the RNF38 RING 4-mutant library. (C) Sequencing analysis and alignment of 
translated DNA sequences of 7 isolates colonies. Sequences are aligned with translated 
wt-RNF38 RING domain with residues: L412, M417, C418, and D419 randomized. 
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anneal upstream of the OmpA leader sequence and downstream of the ClaI restriction site 
verifying ~520 bp fragment in the twelve isolate colonies (Figure 3.4 A). After large-scale 
ligation and plasmid purification, a library size for a 4-mutant library consists of 1.6 x 105 is 
required to have all possible sequences. RNF38 RING 4-mutant library is titered showing a 
potential library size to be ~7.2 * 106 cfus when using commercial XL1-blue cells (Figure 3.4 
B). Sequence analysis sent from 10 isolate colonies reveal 7 of 10 randomized residues at L412, 
M417, C418, and D419 within the RING domain (Figure 3.5 C). Isolates 2 and 6 had a deletion 
causing a frame shift while isolate 10 was not sequenced (data not shown). Isolates 1, 8 and 9 
have missense mutations from either sequencing errors or replication of the plasmid within XL1-
blue cells. 
3.5 Discussion 
 RNF38 RING sequence is similar to many other RING-type E3s following the CXXC 
moiety in the N-terminal loop coordinating with Zn2+, but a majority of E3s use two nonpolar 
residues in between two flanking cysteine residues with the exception of RING domains of 
Table 3.1 Primer for overlap and colony PCR.  
Primers 1 and 2 are designed for flanking the upstream and downstream ends of 
inserted gene. Primers 3-6 are required for amplification of upstream, downstream and 
overlap for RNF38 RING AAAA-mutant fragments and insert. Primers 7-10 are 
designed for 4-mutant library inserts. 
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BARD1, MDMX, Rbx1, cIAP2, Birc7, and Cbl-b from the E3s aligned. Similarly, many RING 
E3s have nonpolar residues such as M or L immediately before and after the CXXC moiety. 
Mutations of C418 and D419 would be thought to be exclusive in charge reversal as C418 
interacts directly with K4 on N-terminal helix of UbcH5B (refer to Figure 1.5 A). RNF38 RING 
AAAA-mutant ligation to pComb vector and transformation into XL1-blue cells could have been 
more efficient if the digestion of pComb-wt-RNF38 RING would have yielded more cut pComb 
vector for the ligation. But the total transformation of colonies for pComb-RNF38 RING AAAA-
mutant could barely be counted as the cells were beginning to grow over one another. Therefore, 
more than 10-fold difference could be speculated between control and 1:3 ligations. Colony PCR 
for the library mutants yield only the ~500 bp fragment similar to the wt-RNF38 RING colony 
PCR. Library titer and sequence analysis for RNF38 RING 4-mutant library do provide evidence 
sequence coverage and all four sites well randomized before starting on library selection. 
3.6 Experimental Procedures 
3.6.1 Alanine mutant screen 
RNF38 RING AAAA mutant was amplified from pComb-wt-RNF38 RING in two 
fragments. The “up fragment”  was prepared in 50 μL reaction with 100 ng pComb-wt-RNF38 
RING, 0.5 μM pComb-TEV-RNF38 up primer (5’-TCCTGCCCGCGGACTAAAGCAGATATT-3’), 0.5 
μM pComb-TEV-RNF38 overlap down primer (5’-AGTCTGTTCTGACTGGTGGTTAGGATTG-3’), 
2X DreamTaq Green PCR Master Mix, and remainder with diH2O. “Up fragment” reaction was 
amplified in thermocycler under following conditions: 95oC for 2:00, (95oC for 30 s, annealing at 
52oC for 30 s, extending at 72oC for 45 s for 35 cycles), 72oC for 4:00 min, and holding @ 4oC. 
The “down fragment” was prepared in a 50 μL reaction with 0.5 μM pComb-TEV-RNF38 
overlap up AAAA primer (5’-
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CAGTCAGAACAGACTGCATGTGTAGTATGCGCAGCAGCATTTGAGTCAAGGCAGCTAC-3’) 0.5 μM 
pComb-TEV-RNF38 down primer (5’-CGTGACTAGTTTCTGAATCCCGATG-3’) and amplified 
under similar conditions as the up fragment. Fragments were run in 1% agarose gel and DNA 
was purified following Qiagen DNA Extraction protocol. 
 Overlap PCR was prepared in a 100 μL reaction with 300 ng “up fragment”, 300 ng 
“down fragment”, 0.5 μM pComb-TEV-RNF38 up primer, 0.5 μM pComb-TEV-RNF38 down 
primer, 2X DreamTaq Green PCR Master Mix, and remainder with diH2O. RNF38 RING 
AAAA mutant overlap PCR was amplified, verified, purified, and quantified under similar 
conditions previously stated.  
 Digestion of pComb-wt-RNF38 RING was prepared in 50 μL reaction with 200 ng 
pComb-wt-RNF38 RING, 1 unit of SacII, 1 of unit SpeI, and 1X Cutsmart Buffer and remaining 
volume with diH2O. Digestion of RNF38 RING AAAA mutant was prepared in 200 μL reaction 
with 1 μg RNF38 RING AAAA-mutant, 1 unit of RE SacII, 1 unit of RE SpeI, 1X Cutsmart 
Buffer, and remaining volume with diH2O. Digestion reactions for pComb-wt-RNF38 RING and 
RNF38 RING AAAA-mutant are incubated in 37oC incubator for 5 hours and overnight, 
respectively. Digestions are verified in 1% agarose gel, excised and purified following Qiagen 
DNA excision protocols. 
 Ligation of pComb vector: RNF38 RING AAAA-mutant in 20 μL reactions with 50 ng 
SacII/ SpeI digested pComb vector, 150 ng SacII/ SpeI digested RNF38 RING AAAA-mutant, 
1X T4 ligase buffer, 1 unit of T4 ligase, and remaining volume with diH2O. Vector-only control 
was set up similarly without insert. Reactions were incubated overnight at 25oC. Transformation 
via electroporation occurred with 1 μL ligation reaction pComb-RNF38 RING AAAA-mutant 
into 50μL XL1-blue cells, then cells were immediately treated with 1 mL SOC media incubating 
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in 37oC shaker for 1 hour. 300 μL of transformed cells are plated onto 2% glucose and 100 μg/ 
mL ampicillin plates incubating overnight in 37oC incubator. Transformation of ligation control 
with SacII/ SpeI digested pComb was prepared similarly. Plasmid purification for each isolate 
colony followed QIAGEN Miniprep Purification protocol. Each purified pDNA was quantified 
with Nanodrop spectrophotometer before diluted to 40- 50 ng/ μL with 0.5 μM primer, Jun13 or 
Jun14 and sent to Genewiz for Sanger Sequence analysis. 
3.6.2 4-mutant library construction 
The 4-mutant library “up fragment”  was prepared in 50 μL reactions with 100 ng 
pComb-RNF38 RING AAAA mutant as a template, 0.5 nM pComb-RNF38 SacI up primer (5’-
GCCTACGAGCTCACTAAAGCAGATATGAACAACTT-3’), 0.5 nM pComb-RNF38-TEV-overlap 
NNK Re primer (5’-GTCTGTGACTGGTGGTTAGG-3’), 2X DreamTaq Green PCR Master Mix 
(Thermo Fischer), and remainder with diH2O. Reactions for “down fragment” was prepared 
similarly, but with 0.5 μM pComb-RNF38-TEV overlap NNK Fw primer (5’- 
CAGTCAGAACAGACTNNKTGTGTAGTATGCNNKNNKNNKTTTGAGTCAAGGCAGC-3’), 0.5 μM    
pComb-RNF38-TEV ClaI down primer (5’-
GGAAGTATCGATTCATTCTGAATCCCGATGCACTTCTG-3’). Both amplified under similar 
conditions as the up fragment. 
Overlap PCR was prepared in a 100 μL reaction with 300 ng “up fragment”, 300 ng 
“down fragment”, 0.5 nM pComb-TEV-RNF38 SacI up primer, 0.5 nM pComb-TEV-RNF38 
ClaI down primer, 2X DreamTaq Green PCR Master Mix, and remainder with diH2O. RNF38 
RING 4-mutant library overlap PCR was amplified, verified, purified, and quantified under 
similar conditions previously stated. 
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Digestion of pComb-7G12 was prepared in a 200 μL reaction with 26 μg pComb-7G12, 1 
unit of SacI, 1 of unit ClaI, and 1X Cutsmart Buffer and remaining volume with diH2O. 
Digestion of RNF38 RING 4-mutant library was prepared in 200 μL reaction with 60 μg RNF38 
RING 4-mutant library, 3 unit of SacI, 3 unit of ClaI, 1X Cutsmart Buffer, and remaining volume 
with diH2O. Digestion reactions for pComb-7G12 and RNF38 RING 4-mutant library are 
incubated in 37oC incubator for 4 hours and overnight, respectively. Digestions are verified in 
1% agarose gel, excised and purified following Qiagen DNA excision protocols. 
Ligation of 1: 10 pComb vector: RNF38 RING 4-mutant library in 10 μL reactions with 
50 ng SacI/ ClaI digested pComb vector, 500 ng SacI/ ClaI digested RNF38 RING 4-mutant 
library, 1X T4 ligase buffer, 1 unit of T4 ligase, and remaining volume with diH2O. Vector-only 
control was set up similarly without insert. Reactions were incubated overnight at 25oC. 
Transformation via electroporation occurred with 1 μL ligation reaction pComb-RNF38 RING 4-
mutant library into 50μL XL1-blue cells, then cells were immediately treated with 1 mL SOC 
media incubating in 37oC shaker for 1 hour. 300 μL of transformed cells are plated onto 2% 
glucose and 100 μg/ mL ampicillin plates incubating overnight in 37oC incubator. 
Transformation of ligation control with SacI/ ClaI digested pComb was prepared similarly. 
Isolate colonies were selected for plasmid purification following QIAGEN miniprep purification 
protocol. 
Large-scale ligation was set up in 1 mL reaction with 2.8 μg SacI/ ClaI digested pComb 
vector, 22 μg SacI/ ClaI digested RNF38 RING 4-mutant library, 1X T4 ligase Buffer, 20 units 
of T4 ligase, and remaining volume with diH2O. Ligation reaction was incubated for 15 hours at 
25oC. Ligation is concentrated to 20 μL following the phenol-chloroform ethanol precipitation 
protocol. Transformation for large-scale ligation was prepared similarly using commercial XL1-
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blue cells. Serial dilution in 10-fold decrease from 50 μL from SOC treated XL1-blue cells. 
Dilutions were plated onto 2% glucose, 100 μg/ mL ampicillin plates with 5 μL serial dilutions. 
Plasmid purification for each isolate colony followed QIAGEN Miniprep Purification protocol. 
Each purified pDNA was quantified with Nanodrop spectrophotometer before diluted to 40 nM 
with 0.5 nM Jun13 or Jun14. Colony PCRs were prepared in 20 μL reactions under similar 
conditions as RNF38 RING model phage selection protocol.  
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4 Phage Display and Selection of RNF38 RING 4-mutant Library 
4.1 Introduction 
 The library will be displayed onto the N-terminal end of pIII protein from M-13 phage. 
Selection of the library using a pseudo-OUT pathway to enrich potential sequences after multiple 
rounds. E3-phage library interacts with charge reversed N-terminal helix (K4E and K8E) of xE2, 
xUbcH5B, to rule out unreactive sequences for RING domain. bE1 will be used for interaction 
with wt-UB-Bio for efficient selections of the current library. Sequences which have undergone 
convergence will then be displayed onto pIII proteins of M13 phage to be tested for activity 
within the OUT pathway. Active sequences termed xRNF38 RING will be inserted into FL-
Figure 4.123Library selection scheme and phage display 
(A) Immunoblot of 1st (left) and 2nd (right) RNF38 RING 4-mutant library with 
anti-FLAG 1o Ab exposed for 30 sec. Phage displayed RNF38 RING 4-mutant 
library is fused to pIII protein to yield ~30 kDa band. (B) Library selection scheme 
for autoubiquitination of phage displayed E3 RING domain library with N-terminal 
FLAG tag. bE1 (UFD domain is mutated) interacts with wt-Bio-UB similar to wt-
E1 but interacts with xE2 only. xE2 will then transfer Bio-UB to its catalytic Cys 
residue before interacting with active sequences from phage-displayed E3 RING 
domain library. Active phage-displayed E3 RINGs will undergo autoubiquitination 
to a lysine residue within the E3 RING domain. Bio-UB will be pulled down onto 
streptavidin-coated plates then washed after binding to remove unbound phage. 
TEV cleavage by TEV protease occurs to free bound phage to infect XL1-blue cells 
for to generate the selected sequences for the new library. 
A B 
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RNF38 to be expressed in HEK293 cell line to test activity of FL-xRNF38 within the OUT 
pathway. 
Figure 4.224Library selection with phage titers. 
(A) Input phage for each round of library selection. Final phage concentration for 
each selection is 1 x 1011 pfus for effective phage-displayed E3 RING library to 
interact with xE2. (B) Library selection titers represented in a bar graph. The “+” 
reactions are usually at least 10-fold higher compared to three negative controls. (C) 
Library selection titers represented in numerical table. The positive “+” show almost 
~100-fold increase in pfu compared to three negative controls. The 4th library shows 
a 10-fold increase in activity compared to the other libraries which may lead to 
decrease overall E3 RING-phage selection. 
B 
A 
C 
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4.2 Selection of 4-mutant library 
 Native RNF38 RING 4-mutant library displays on pIII protein of M-13 phage before 
selecting out active sequences through a pseudo OUT cascade (Figure 4.1 A). Each library-
phage is displayed to verify successful fusion of E3 RING library to pIII before selection of the 
library can occur. The pseudo OUT cascade is a hybrid system of wt-UB cascade and OUT 
cascade to select out xE2-xE3 pair from a library of E3 RING domain mutants (Figure 4.1 B). 
The selection scheme uses bE1 to interact with wt-Bio-UB with wt-AD and xE2 with mutant 
UFD (refer to Figure 1.7). wt-Bio-UB is transferred to catalytic Cys from xE2 then through the 
xE2 binding interface to select for active phage-displayed E3 RING sequences are 
polyubiquitinated. Polyubiquitinated E3 RING sequences are pulled down with streptavidin and 
washed to remove unbound E3-phage. Bound E3-phage undergo TEV cleavage to release the 
phage to infect XL1-blue cells before selection titers and purifying the new selected library. 
 Each library-phage is quantified by a phage titer before selection of the library for 
keeping the phage input of 1 x 1011 pfus for every selection to ensure many E3 RING library is 
displayed on the phage for streptavidin pull-down (Figure 4.2 A). After XL1-blue cells are 
infected, selection titers are monitored for each library selection and compared with three 
negative controls (Figure 4.2 B & C). The selection titers representation as a bar graph helps 
visually monitor the efficiency where the “+” reaction is roughly 10-100-fold higher in pfu 
compared to the three negative controls: “-bE1”, “-xE2”, and “-UB”. Selections leading to the 4th 
library show a slight 9-fold increase in pfus while monitoring “-bE1” control. Each library after 
selection undergoes double digestion with REs, SacII and ClaI, on pComb-RNF38 RING 4-
mutant library from purified isolates before sequence analysis (Figure 4.3 A). Digestion results 
leading up to the 4th library show significant decrease in the amount of RNF38 RING 4-mutant 
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library. Therefore, the 4th library undergoes a technique known as sub-cloning to clean up the 4th 
library before continuing in the selection process. 
Figure 4.325Selection library verification 
(A) Scheme for double digestion of purified pComb-RNF38 RING 4-mutant library 
isolates after library selection. XL1-blue cells infected with the selected library are grown 
on selective media to monitor selection titers. Isolate colonies from the positive reaction 
grown in selective media have pDNA purified then digested with two restriction enzymes 
(REs), SacII and ClaI. Library quality is measured from the number of digested fragments 
and isolates with the correct size fragment are sent for sequence analysis. (B) Double 
digestion with REs, SacII and ClaI, on 10 isolates from the 4th library selection showing 4 
of 10 isolates with the RNF38 RING 4-mutant library-pIII conjugate with ~500 bp band 
(top). A contaminant with similar RE sites is observed by the ~1700 bp band and the 
digested pComb vector with a ~3000 bp band. The 4th library undergoes sub cloning to 
improve library quality for the next selection round. Double digestion for 10 isolates from 
the 5th library selection shows 9 of 10 isolates with ~500 bp band consistent with RNF38 
RING 4-mtatant library (bottom). Two isolates have the contaminant with a ~1700 bp 
band and all isolates have the digested pComb vector at ~3000 bp band. 
A B 
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4.3 4th library sub cloning 
 The 4th RNF38 RING 4-mutant library (4th library) shows decreasing quality of the 
library after verifying ten isolates with double digestion (Figure 4.3 B). A sub cloning for the 4th 
library is used to improve the library by double digestion with REs, SacI and ClaI, and ligated 
into SacI/ ClaI digested pComb vector. A ligation with 1:5 ratio of digested pComb vector to 4th 
library and vector only control yield ~660 cfu and 1 cfu, respectively (data not shown). Double 
digestion with REs SacII/ ClaI confirm successful ligation of the 4th library as all ten isolates 
show ~3.0 kb band consistent with digested pComb vector and ~500 bp band consistent with 4th 
Table24.1 Sequence convergence for the 5th library.  
Sequence analysis from several isolates of the 5th library shows convergence of sequences of 
the four mutation sites. Several isolates from the 5th library selection are compared to wt-
RNF38 RING at positions: 412, 417, 418, and 419. Letters represent amino acid residues 
where converged positions are highlighted in the following: non-polar (gray), basic (blue), 
small chain and polar (yellow), and long chain and polar (green). Met417 is converged to Leu 
residues, Cys418 has converged to Thr/ Ser or Arg/Lys residues, and Asp419 shows some 
convergence with Arg/His/Lys or Asn/Gln residues. 
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library-pIII conjugate (data not shown). The sub cloned 4th library then undergoes selection for 
the 5th library yielding very little pfus from negative control (Figure 4.3 A). Double digestion 
with REs, SacII and ClaI, for ten isolates results result in 9 of 10 isolates with ~500 bp band for 
5th library-pIII conjugate (Figure 4.3 B). 
4.4 Sequence Analysis for the 5th library 
 Selection for the 5th library shows ~100-fold difference between “-bE1” control and 
almost ~1000-fold difference between “-xE2” and “-UB” controls with relatively pure library 
from several isolates digested with REs, SacII and ClaI. Sequences analysis for digested isolates 
Figure 4.426Loop stability affects activity in pseudo-OUT cascade 
Autoubiquitination of three xRNF38 RING mutants with differing residues for L412 
mutation but other three residues are relatively similar. FLAG-xRNF38 RING-pIII is 
~35 kDa band in IB: FLAG at 1 min exposure with lanes left to right: +, -bE1, -xE2, 
and -HA-UB. Polyubiquitin chain is shown for “+” reaction only when compared to 
negative controls. L412G from isolate 4S-4-3 shows some activity, L412 from isolate 
4S-5-21 show highest activity, and L412K from isolate 4S-5-28 does not show activity. 
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reveal a convergence within three positions from RNF38 RING domain: M417, C418, and D419 
(Table 4.1). Met417 has converged to Leu residue to resemble characteristics of methionine. 
Interestingly, Cys418 has converged to similar residues such as threonine and serine, but also 
arginine and lysine with a longer chain. Lys/ Arg residues can electrostatically interact with K4E 
or K8E on N-terminal helix of xUbcH5B. Asp419 did not show as much of a convergence, but 
Arg/ Lys and Asn/ Gln seem to reoccur. Theoretically, D419R/K would present an electrostatic 
interaction with K8E; however, the amide group of D419N/Q would potentially form a hydrogen 
bond with K8E. Isolates are selected based on retaining stability for the Zn2+ interacting loop, 
potential electrostatic or hydrogen bond formation with mutations on N-terminal helix of xE2. 
4.5 Activity of xRNF38 RING in OUT cascade 
 Isolates 4S-4-3 (GLTK), 4S-5-21 (LLTR), and 4S-5-28 (KLSQ) are selected to determine 
if loop stability is necessary to form an interaction with xE2 within a pseudo-OUT cascade 
(Figure 4.4).The three isolates have similar residue mutations for M417L, C418S/T, and 
D419K/R/Q. which can help determine  Isolate 4S-4-3 uses L412G mutation to introduce a 
flexible residue to allow for loop flexibility, but according to the data xRNF38 only has slight 
autoubiquitination after interacting with xUbcH5B. Isolate 4S-5-21 retains L412 and shows 
highest activity through polyubiquitin chain formation. Isolate 4S-5-28 has L412K mutation 
changing the polarity which may affect activity as no ubiquitin chains formed. These three 
isolates are tested in vitro in the OUT cascade to obtain further evidence if loop stability affect 
xE2-xRNF38 RING interaction. 
4.6 Discussion 
bE1, bUba1, is used for selection to allow wt-UB-Bio to be transferred to RNF38 RING 
4-mutant library-phage as the sequences interact with xE2. Autoubiquitination of RNF38 RING 
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4-mutant library-phage with UB-Bio will be pulled out with streptavidin plates, and to ensure 
selections are efficient the “+” reaction is compared to three negative controls. “-bE1” reaction is 
important to compare the “+” reaction because wt-UB-Bio cannot be transferred if there is no 
bE1 to activate UB with ATP to allow for reactive thiol from bUba1 to transfer UB-Bio to xE2.  
There is a strong possibility that RNF38 RING AAAA-mutant-phage could have 
contaminated the 2nd and 3rd libraries due to the abundance of the sequences with this genotype. 
The contaminant with ~1700 bp band is not known since non-RNF38 RING sequences did not 
have a sequence analysis with anything over 1200 bp, therefore, the source is still unknown. 
Nevertheless, sub cloning the 4th library is necessary to continue the selection of the library, and 
the sub cloning is very successful since the ligation ratio 1:5 control: 4th library is more than 99% 
4th library. The digestion for the sub cloned pComb-4th library-phage result in 100% 4th library 
fragment further proving minimal contamination. Sequence analysis for the sub cloned 4th 
library-phage also shows no sequences with AAAA-mutant because pComb-RNF38 RING 
AAAA-mutant is digested with SacII/ ClaI and cannot be fully digested since SacI RE site is not 
present within the sequence. 
Selection after sub cloning has proven very effective only after fifth trial for 5th library as 
the selection titer is ~17-fold higher compared to the selection titer for the 4th library. The fourth 
trial did not yield any significance between any of the reactions due to lack of growth from old 
ampicillin plates and the same plates are tested with the 5th library-phage from fourth trial 
selection producing similar results for lack of growth. Hence a fifth trial for the selection of the 
5th library provides the best results, but isolate colonies from the fourth trial provide some 
evidence for convergence of sequences. 
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4.7 Experimental Procedures 
4.7.1 Phage display of RNF38 RING 4-mutant library 
Phage display for library mutants was similar prepared similarly to wt-RNF38 RING 
phage display except for the use of commercial XL1-blue cells in transformation. Phage titers 
and western blots for library phage display was prepared similarly. 
4.7.2 RNF38 RING library selection 
Selection assay for RNF38 RING libraries was conducted in 250 μL reactions with bE1, 
bUba1 (1 μM), xUbcH5B (10 μM), RNF38 RING 4-mutant-library-phage (1 x 1011 pfus), UB-
Bio (0.2 μM), ATP pH 7.6 (5 μM), 1 X Tris HCl / MgCl2, 0.1 mM DTT, and remaining volume 
with diH2O. Three controls: -E1, -E2, and -UB are also conducted to serve as negative controls 
in 50 μL reactions. Reactions were incubated for 2 hr in 37oC shaker then transferred to 
streptavidin-coated wells in 1:1 reaction: 3% BSA in 1X PBS. Wells were incubated for 1 hr on 
orbital shaker at room temperature before being washed 20X with 1X PBS Buffer. Wells were 
incubated for 45- 60 min in 30oC with 100 μL TEV solutions of 1X ProTEV Buffer (1M HEPES 
pH 7.0 and 10 mM EDTA), DTT (0.1 mM), 1 u/μL ProTEV Protease (50 mM Tris HCl (pH 7.5), 
500 mM NaCl, 5 mM DTT, 1 mM EDTA, 50% glycerol, and 0.1% Triton X-100), and remaining 
volume with diH2O. Cleaved phage were incubated for 1 hr in 37
oC shaker in XL1-blue cells 
(OD600 ~0.7). Serial dilution for each reaction was prepared similarly as phage titer. Isolate 
colonies were prepared similarly to RNF38 RING AAAA-mutant. Digestion of the isolates were 
prepared in 20 μL reactions with 10 μL digestion master mix (2 u/μL SacII, 1 u/ μL ClaI, 1X 
Cutsmart Buffer, and remaining with diH2O) and 10 μL purified pDNA incubating for 1 hr in 
37oC incubator. Reactions were verified under similar conditions as digestion of RNF38 RING 
4-mutant library with SacI/ ClaI. 
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4.7.3 4th Library Digestion, Ligation, and Transformation 
 Digestion, ligation, and transformation of the 4th RNF38 RING 4-mutant library was 
prepared similarly to RNF38 RING 4-mutant library, but with a 1:5 ligation of vector: insert. 
Large scale ligation was prepared similarly to RNF38 RING 4-mutant library. 
4.7.4 Selection conditions for 6th library 
 Selection assay for the 6th library was prepared similarly except for the decrease in total 
5th RNF38 RING 4-mutant library-phage concentration was decreased to 5 x 109 pfus and 
increase of DTT to 0.2 mM. 
4.7.5 Ubiquitination Assay in OUT cascade 
Autoubiquitination for xRNF38 RING mutants within the pseudo-OUT cascade was 
prepared in 25 μL reactions with bE1, bUba1 (1 μM), xE2, xUbcH5B (10 μM), xE3-phage, 
xRNF38 RING mutant-phage (1x1011 pfus), HA-UB (40 μM), ATP pH 7.6 (5 μM), 1 X HEPES / 
MgCl2, 0.1 mM DTT, and remaining volume with diH2O. Three controls: -bE1, -xE2, and -UB 
are also conducted to serve as negative controls for auto-ubiquitination. Reactions were 
incubated for 20 h in 37oC shaker and stopped with 2X Lamelli with BME loading dye. 
Reactions were run following similar conditions as the western blot for wt-RNF38 phage with 1: 
1500 α-GST 1o Ab and 1: 10000 α-mouse-HRP conjugate 2o Ab. 
 Autoubiquitination for xRNF38 RING mutants within the OUT cascade was prepared 
similarly as the pseudo-OUT cascade except with xE1, xUba1 (1 μM) and xUB-HA (20 μM). 
The western blot was also prepared similarly as wt-RNF38 phage. 
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5 CONCLUSION and FUTURE WORK 
 wt-RNF38 RING domain shows activity in autoubiquitination by interacting with 
UbcH5B through the E2-binding domain, and shows substrate, p53, ubiquitination in vitro 
through the recognition of p53 in the substrate binding domain. Phage-displayed RNF38 RING 
shows autoubiquitination activity without interference from pIII protein on M-13 phage. RNF38 
RING 4-mutant library is successfully generated with 10-fold higher cfus to cover all possible 
sequences and ligated to the pComb phagemid. Sequence convergence for 3 out of 4 key 
residues, M417L, C418S/T or C418R/K, and D419R/K are achieved for the xE2-xE3 pair after 
four rounds of selection. The Zn2+ interacting loop on xRNF38 RING mutants, the xE2-xE3 
interface, is important for xUbcH5B recognition before autoubiquitination of xE3 occurs. 
 Substrate ubiquitination with p53 xRNF38 RING mutants needs to be confirmed before 
testing activity of FL-xRNF38. xRNF38 RING needs to be inserted into FL-RNF38 to determine 
activity in vivo in HEK293T cells. Ubiquitination of substrates in vivo in HEK293T cells after 
tandem purification using HBT-UB (Hexahistidine-Biotin-UB) using both Ni-NTA column 
purification followed by streptavidin column purification will then undergo trypsin digestion. 
Proteomics for ubiquitinated substrates will by LC/MS determines potential substrates for 
xRNF38 to help understand the function of this RING-type E3 in the cell.
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